Center for iPS Cell Research Application (CiRA) of Kyoto University and Takeda Pharmaceutical Company Limited (Takeda) announced today that they will work together to develop clinical applications of ...
A group of researchers in Japan says it has confirmed a certain level of efficacy in using iPS cell-derived immune cells for ...
Japanese researchers have made progress in the treatment of spinal cord injuries, offering hope to the approximately 20 million people worldwide affected by paralysis. On March 21, scientists from ...
I Peace will provide its GMP iPS cell-related technology to generate the MCB's for the parent line and the modified subclones, while Vita will provide the technology necessary for gene editing and ...
With a Kobe University-developed procedure, induced pluripotent stem cells can now be frozen directly in their dishes without losing their viability or undifferentiated state after thawing. This marks ...
TOKYO & MONT-SAINT-GUIBERT, Belgium--(BUSINESS WIRE)--BrightPath Bio (Tokyo Stock Exchange Growth 4594, “BrightPath”), a pioneer in iPS cell-derived Natural Killer T (“NKT”) cell therapy, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results